Patients Treated with Liraglutide Are More Likely to Reach Target HbA1c Compared with Sitagliptin or Exenatide BID
Keyword(s):
2012 ◽
Vol 14
(7)
◽
pp. 626-633
◽
Keyword(s):
2011 ◽
Vol 27
(12)
◽
pp. 2335-2342
◽
2014 ◽
Vol 30
(7)
◽
pp. 1209-1218
◽
2014 ◽
Vol 48
(5)
◽
pp. 571-576
◽
Keyword(s):